{"id":"W4252073357","doi":"10.1097/00054725-200705005-00064","title":"Certolizumab pegol improves HRQoL in patients with Crohnʼs disease: Data from PRECiSE 2","year":2007,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Certolizumab pegol; Medicine; Tolerability; Crohn's disease; Placebo; Internal medicine; Randomization; Clinical trial; Infliximab; Disease; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003984498,0.0009424404,0.001601644,0.0004060372,0.0002946204,0.0006660736,0.0003939801,0.0008401242,0.001806397],"category_scores_gemma":[0.003305704,0.000261888,0.002506542,0.0005116921,0.0004566179,0.0004594578,0.0004028428,0.0009866341,0.000269475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002603984,"about_ca_system_score_gemma":0.0006097834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008598411,"about_ca_topic_score_gemma":0.001867134,"domain_scores_codex":[0.9988695,0.0005761262,0.0002023514,0.00007250502,0.0001878731,0.00009164208],"domain_scores_gemma":[0.9978041,0.000831483,0.0006175222,0.0001904278,0.0002841585,0.0002722772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6698827,0.0109143,0.0546301,0.006731108,0.01194782,0.0005886531,0.0006502865,0.001376416,0.01590824,0.0002122165,0.007513588,0.2196446],"study_design_scores_gemma":[0.2610535,0.3448552,0.353763,0.0008499796,0.01157137,0.000966366,0.0002543884,0.0007239056,0.005427312,0.0001929982,0.02018889,0.0001530964],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9327959,0.05685559,0.0005666085,0.001291552,0.0002355682,0.0009484448,0.004127631,0.00005874995,0.003120097],"genre_scores_gemma":[0.9594193,0.02919901,0.001262586,0.001771365,0.0004711859,0.000636717,0.005861239,0.00001781917,0.001360695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003984498,"threshold_uncertainty_score":0.02107227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007809086974375181,"score_gpt":0.233255711541331,"score_spread":0.2254466245669558,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}